Insulin delivery devices market to reach $28.03 billion by 2030

The Business Research Company says the global insulin delivery devices market is set to grow from $19.07 billion in 2025 to $20.61 billion in 2026, with further expansion to $28.03 billion by 2030. Rising diabetes cases, home care adoption and demand for easier self-injection are driving the market, with Asia-Pacific expected to post the fastest growth.

Why it matters: - Insulin delivery devices are a core part of diabetes management for people who need controlled insulin administration. - Rising diabetes cases are pushing demand for more convenient, portable and home-based treatment options. - Market growth signals continued investment in devices that can support long-term blood sugar control and self-care.

What happened: - The Business Research Company published a global market report on insulin delivery devices. - The market is projected to rise from $19.07 billion in 2025 to $20.61 billion in 2026, a CAGR of 8.1%. - The market is forecast to reach $28.03 billion by 2030, implying a CAGR of 8.0% over the period. - North America led the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample and the full report are available online: Download a free sample and View the full report.

The details: - Insulin delivery devices are medical instruments used to administer insulin to people with diabetes. - These devices help regulate blood glucose levels when the body does not produce enough insulin naturally. - The report links market growth to rising diabetes cases, better awareness of diabetes care, wider insulin availability, improved healthcare access and growing self-injection adoption. - The report points to a shift toward insulin pens instead of traditional syringes. - The report also cites growing use of insulin pumps for steady delivery. - Demand is rising for portable and easy-to-use devices. - At-home diabetes management tools are gaining traction. - Disposable and pre-filled insulin devices are becoming more popular. - The International Diabetes Federation reported about 589 million adults ages 20 to 79 were living with diabetes in 2024. - The International Diabetes Federation projects that figure will reach 853 million by 2050. - Sedentary lifestyles, poor eating habits and rising obesity rates are helping drive diabetes prevalence.

Between the lines: - The forecast suggests insulin delivery is moving further away from clinic-only care and toward daily self-management. - The strongest growth drivers are practical, not experimental: convenience, home use and broader access to treatment. - The regional split points to mature demand in North America and faster adoption potential in emerging markets.

What's next: - The market is likely to keep shifting toward devices that simplify self-administration and support long-term use. - Emerging economies with improving healthcare access are likely to add to demand. - Home healthcare adoption should keep supporting sales of pens, pumps and disposable devices. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

The bottom line: - Insulin delivery devices are on track for steady growth as diabetes prevalence rises and patients increasingly choose easier, more flexible ways to manage insulin.